Sp196
METHYLATED DNA BIOMARKERS IN PANCREATIC JUICE FOR PANCREATIC CANCER DETECTION
Date
May 6, 2023
Explore related products in the following collection:
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
AGA Autoimmune Pancreatitis: Current Concepts
Session will review the diagnosis and treatment of autoimmune pancreatitis…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
MOLECULAR DETECTION OF PANCREATIC NEUROENDOCRINE TUMORS USING PLASMA METHYLATED DNA MARKERS
BACKGROUND: Colonic polyposis, which is a risk factor for colorectal cancer (CRC), can be driven by a pathogenic variant in a polyposis gene. However, in many cases germline genetic testing is negative, leaving the cause of the polyposis unknown…